The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
New Forecast Predicts Rebound In Countries With Low Fertility Rates
A new statistical method to forecast fertility rates around the world predicts an unexpected rebound in countries with low fertility rates.
WWF: End Poaching On Global Tiger Day
The WWF calls for an end to poaching to save the wild tiger population, whose numbers today stands at only 3,200.
Million Dollar Shaw Prize Awarded For Cosmology, Immunology & Geometry
Seven scientists have won the 2011 Shaw Prize for their pioneering work on gamma ray bursts, innate immunity, and modern geometry and physics.
Trial Begins For Vaccine Against Ross River Virus
Perth researchers are seeking volunteers to test the effectiveness of a vaccine against the debilitating Ross River Virus.
Chinese Researchers Link Gene Regions To Squamous-Cell Carcinoma
Scientists in China have identified new gene regions associated with esophageal squamous-cell carcinoma.
Stem Cell Pioneer Yamanaka Discovers New Factor, Glis1, For iPS Cell Production
Yamanaka and colleagues have discovered that a new transcription factor Glis1, enriched in unfertilized and recently fertilized eggs, could replace Myc to produce iPS cells.
Researchers Find Immunity Switch Using A Super Microscope
Researchers have used an ultra powerful microscope to discover how T-cells, the front-line troops of the immune system, are activated.
New Virulent Bacterial Strain Identified As Cause Of European Outbreak
Researchers from BGI China have identified a virulent new strain of Escherichia coli as the cause of the recent outbreak in Europe.
CrystalGenomics Starts Phase IIb Study For Osteoarthritis
CG Pharmaceuticals, Inc. has enrolled the first patient for a Phase IIb clinical study of its novel NSAID candidate.